Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase
Rivaroxaban 10 mg once daily has been FDA-labeled for thromboprophylaxis after high-risk hospitalization of medical patients and after total hip or knee replacement surgery
While some studies have shown potential benefits positively affecting certain brain functions, much of the evidence comes from small studies or animal studies
Insilico Phase IIa in IPF
Mallick R, Basak S, Duttaroy AK (2019) Docosahexaenoic acid,22:6n3: Its roles in the structure and function of the brain